Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeRemission InductionCyclophosphamideMelphalanMultiple MyelomaTransplantation, HomologousTransplantation ConditioningSalvage TherapyLymphoma, Non-HodgkinAntineoplastic AgentsDisease-Free SurvivalEtoposideCytarabineHodgkin DiseaseRecurrenceStem CellsSurvival RateVincristineBone Marrow TransplantationMyeloablative AgonistsCarmustineSurvival AnalysisDoxorubicinGraft vs Host DiseaseHematopoietic Stem Cell MobilizationThiotepaChemotherapy, AdjuvantBone Marrow PurgingPrognosisHematologic NeoplasmsWhole-Body IrradiationRetrospective StudiesLymphoma, Mantle-CellFollow-Up StudiesBusulfanAntibodies, Monoclonal, Murine-DerivedDexamethasoneAmyloidosisHematopoietic Stem CellsLeukemia, Myeloid, AcuteAntineoplastic Agents, AlkylatingBoronic AcidsPrednisonePyrazinesLymphoma, FollicularIfosfamideTime FactorsGraft SurvivalInduction ChemotherapyLymphoma, T-Cell, PeripheralAntigens, CD34ThalidomideNeoplasm, ResidualGranulocyte Colony-Stimulating FactorLymphomaAutograftsCisplatinLiver TransplantationLymphoma, Large B-Cell, DiffuseLeukapheresisPodophyllotoxinIdarubicinMaintenance ChemotherapyDrug Administration ScheduleDose-Response Relationship, DrugMesenchymal Stem Cell TransplantationMitoxantroneTransplantation ChimeraLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaTissue DonorsNeoplasm Recurrence, LocalProspective StudiesMyelodysplastic SyndromesCarboplatinLymphoma, B-CellCord Blood Stem Cell TransplantationNeoplasms, Second PrimaryImmunosuppressive AgentsAntibodies, MonoclonalNeoplasm StagingCell TransplantationLeukemia, Plasma CellAcute DiseaseKidney TransplantationLeukemiaBone MarrowMethotrexateBleomycinRemission, SpontaneousEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsNeutropeniaFeasibility Studies